Company: OTSA
Filing Date: 2025-07-16
Form Type: F-1/A
Source: 0001213900-25-064434
Chunk: 308

Company: OTSAW Ltd
Filing Date: 2025-07-16
Form: F-1/A
Chunk 308
---
 Otsaw has benefitted from Swisslog Healthcare’s longstanding relationships and goodwill with many of our target customers in healthcare globally, providing Otsaw with an immediate customer base, market access and entry channels to the healthcare market in Europe and APAC. This has enabled us to cross sell our AMR platforms (the O -R3and Camello +) and UV -CLED disinfection solutions (TReX, AirGuard, and O -RX), in synergy with the TransCar system, utilizing Swisslog Healthcare’s global marketing channels. Ultimately, we expect the Otsaw -SwisslogJV to continue delivering efficient, cost -effectiveand reliable AI -enabledfacilities management solutions for hospitals and the healthcare industry, covering hospital intralogistics, security, housekeeping and disinfection. Key Arrangement of the Otsaw-Swisslog JV The Otsaw -SwisslogJV was owned 40% by Swisslog Healthcare and 60% by Otsaw Technology Solutions Pte Ltd. when the JV was set up. The shareholding by Otsaw Technology Solutions Pte Ltd was subsequently increased to 73.33% on January12, 2023, 86.66% on November16, 2023, 93.3% on January11, 2024, and 100% on January20, 2025. The respective rights of Swisslog Healthcare and Otsaw Technology Solutions Pte Ltd in respect of the Otsaw -SwisslogJV are set forth in the: 1) shareholders agreement dated November30, 2021 (as amended on November30, 2023) F-29 OTSAW LIMITED AND ITS SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 30 APRIL 2024 16.Otsaw-Swisslog Healthcare Joint Venture (cont.) entered into between (i) Otsaw Technology Solutions Pte Ltd; (ii) Swisslog Healthcare; and (iii) Otsaw -SwisslogJV (the “Shareholders Agreement”); 2) the master asset sale agreement dated November16, 2021 entered into between (i) Swisslog Healthcare; (ii) Otsaw Technology Solutions Pte Ltd; and (iii) Otsaw Digital Pte. Ltd (the “Master Asset Sale Agreement”) and 3) the umbrella agreement dated November30, 2024 entered into between (